EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #73652_C
表观遗传修饰剂；抑制SIRT1组蛋白去乙酰化酶
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
总览
EX527是一种细胞渗透性、选择性哺乳动物sirtuin 1（SIRT1；IC₅₀=98 nM）的抑制剂，且对SIRT2和SIRT3有抑制作用，但对其他组蛋白去乙酰化酶（HDAC）无作用（Nayagam et al.）。SIRT1是一种烟酰胺腺嘌呤二核苷酸（NAD）依赖性去乙酰化酶，在能量代谢和炎症中发挥作用。研究表明，EX527通过与NAD+衍生的副产物形成三聚体sirtuin复合物来抑制sirtuin（Gertz M et al.）。
分化
·促进体外神经干细胞和神经祖细胞分化为少突胶质细胞（Rafalski et al.）。
免疫学
·恢复脓毒症小鼠模型低炎症期的微血管反应，并增强全身先天免疫反应（Vachharajani et al.）。
疾病建模
·延缓PKD1基因敲除小鼠模型肾脏囊肿生长（Zhou et al.）。
别名
Selisistat
细胞类型
神经干/祖细胞，肾脏细胞
种属
人，小鼠，非人灵长类，其它细胞系，大鼠
应用
分化
研究领域
疾病建模，免疫
CAS 编号
49843-98-3
化学式
C₁₃H₁₃ClN₂O
分子量
248.7 克/摩尔
纯度
≥98%
通路
表观遗传学
靶点
HDAC
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
相关材料与文献
文献 (5)
SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. Journal of leukocyte biology 2014 NOV
Abstract
Mechanism-based sepsis treatments are unavailable, and their incidence is rising worldwide. Deaths occur during the early acute phase of hyperinflammation or subsequent postacute hypoinflammatory phase with sustained organ failure. The acute sepsis phase shifts rapidly, and multiple attempts to treat early excessive inflammation have uniformly failed. We reported in a sepsis cell model and human sepsis blood leukocytes that nuclear NAD+ sensor SIRT1 deacetylase remodels chromatin at specific gene sets to switch the acute-phase proinflammatory response to hypoinflammatory. Importantly, SIRT1 chromatin reprogramming is reversible, suggesting that inhibition of SIRT1 might reverse postacute-phase hypoinflammation. We tested this concept in septic mice, using the highly specific SIRT1 inhibitor EX-527, a small molecule that closes the NAD+ binding site of SIRT1. Strikingly, when administered 24 h after sepsis, all treated animals survived, whereas only 40% of untreated mice survived. EX-527 treatment reversed the inability of leukocytes to adhere at the small intestine MVI, reversed in vivo endotoxin tolerance, increased leukocyte accumulation in peritoneum, and improved peritoneal bacterial clearance. Mechanistically, the SIRT1 inhibitor restored repressed endothelial E-selectin and ICAM-1 expression and PSGL-1 expression on the neutrophils. Systemic benefits of EX-527 treatment included stabilized blood pressure, improved microvascular blood flow, and a shift toward proimmune macrophages in spleen and bone marrow. Our findings reveal that modifying the SIRT1 NAD+ axis may provide a novel way to treat sepsis in its hypoinflammatory phase.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nature cell biology 2013 JUN
Abstract
Oligodendrocytes-the myelin-forming cells of the central nervous system-can be regenerated during adulthood. In adults, new oligodendrocytes originate from oligodendrocyte progenitor cells (OPCs), but also from neural stem cells (NSCs). Although several factors supporting oligodendrocyte production have been characterized, the mechanisms underlying the generation of adult oligodendrocytes are largely unknown. Here we show that genetic inactivation of SIRT1, a protein deacetylase implicated in energy metabolism, increases the production of new OPCs in the adult mouse brain, in part by acting in NSCs. New OPCs produced following SIRT1 inactivation differentiate normally, generating fully myelinating oligodendrocytes. Remarkably, SIRT1 inactivation ameliorates remyelination and delays paralysis in mouse models of demyelinating injuries. SIRT1 inactivation leads to the upregulation of genes involved in cell metabolism and growth factor signalling, in particular PDGF receptor α (PDGFRα). Oligodendrocyte expansion following SIRT1 inactivation is mediated at least in part by AKT and p38 MAPK-signalling molecules downstream of PDGFRα. The identification of drug-targetable enzymes that regulate oligodendrocyte regeneration in adults could facilitate the development of therapies for demyelinating injuries and diseases, such as multiple sclerosis.
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. The Journal of clinical investigation 2013 JUL
Abstract
Autosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2 and is characterized by the development of multiple bilateral renal cysts that replace normal kidney tissue. Here, we used Pkd1 mutant mouse models to demonstrate that the nicotinamide adenine dinucleotide-dependent (NAD-dependent) protein deacetylase sirtuin 1 (SIRT1) is involved in the pathophysiology of ADPKD. SIRT1 was upregulated through c-MYC in embryonic and postnatal Pkd1-mutant mouse renal epithelial cells and tissues and could be induced by TNF-α, which is present in cyst fluid during cyst development. Double conditional knockouts of Pkd1 and Sirt1 demonstrated delayed renal cyst formation in postnatal mouse kidneys compared with mice with single conditional knockout of Pkd1. Furthermore, treatment with a pan-sirtuin inhibitor (nicotinamide) or a SIRT1-specific inhibitor (EX-527) delayed cyst growth in Pkd1 knockout mouse embryonic kidneys, Pkd1 conditional knockout postnatal kidneys, and Pkd1 hypomorphic kidneys. Increased SIRT1 expression in Pkd1 mutant renal epithelial cells regulated cystic epithelial cell proliferation through deacetylation and phosphorylation of Rb and regulated cystic epithelial cell death through deacetylation of p53. This newly identified role of SIRT1 signaling in cystic renal epithelial cells provides the opportunity to develop unique therapeutic strategies for ADPKD.
更多信息
| Molecular Weight | 248.7 g/mol |
|---|---|
| 种属 | Human, Mouse, Non-Human Primate, Other, Rat |
| Alternative Names | Selisistat |
| Cas Number | 49843-98-3 |
| Chemical Formula | C₁₃H₁₃ClN₂O |
| 纯度 | ≥ 98% |
| Target | HDAC |
| Pathway | Epigenetic |
相关产品
-
NeuroCult™ NS-A 扩增试剂盒（人）培养人神经干细胞和祖细胞的培养基
-
BrainPhys™神经元培养基提升神经元功能的无血清基础培养基
-
抗少突胶质细胞标志物O4抗体，克隆81小鼠抗人、小鼠、大鼠少突胶质细胞标记物O4的单克隆IgM抗体
-
西尔替诺（Sirtinol）表观遗传修饰剂;Sir2p，SIRT1和SIRT2的抑制剂
